May 3, 2013- Interviewed by Steven E. Greer, MD
Paul Biddinger, MD, Medical Director for Emergency Preparedness, Massachusetts General Continue reading
May 3, 2013- Interviewed by Steven E. Greer, MD
Paul Biddinger, MD, Medical Director for Emergency Preparedness, Massachusetts General Continue reading
May 3, 2013- Interviewed by Steven E. Greer, MD Continue reading
April 27, 2013 By Steven E. Greer, MD
On April 15, 2013, at 2:49 PM, two terrorist bombs exploded at the finish line of the Boston Continue reading
April 25, 2013- Interviewed by Steven E. Greer, MD
With former President George W. Bush receiving a coronary stent and cardiac chest CT-scan, Continue reading
April 24, 2013 By Steven E. Greer, MD
In July of 2012, the New York Times reported on an FDA scandal of the agency spying on internal Continue reading
April 20, 2013 By Steven E. Greer, MD
Only two days after the April 15th Boston Marathon terrorist bombings, Harvard surgeon Atul Continue reading
Interviewed by Steven E. Greer, MD
The clinical adoption of Transcatheter Aortic Valve Replacement (TAVR) has been slower than Continue reading
April 12, 2013- Interviewed by Steven E. Greer, MD
William O’Neill, MD, Director of the Structural Heart Disease Center at Henry Ford Hospital, Continue reading
March 26, 2013
Which smartphone apps will the FDA label as a medical device making them taxable tax under Continue reading
March 26, 2013 Interviewed By Steven E. Greer, MD Continue reading
March 10, 2013 By Steven E. Greer, MD The Healthcare Channel
PREVAIL, the much anticipated second major trial of the Boston Scientific device called Watchman was a bust. The trial endpoints were changed in midstream of the trial, but it still did not help. The efficacy endpoint was not met this time, contradicting the first major trial, PROTECT, where a small efficacy was found. (Even if the statistical endpoints were met, the primary endpoint was a clinically meaningless composite of stroke, systemic embolization, and cardiovascular caused death.)
The safety of the device has always been the show stopper. Continue reading
March 10, 2013 By Steven E. Greer, MD The Healthcare Channel
The main reason that Medicare has limited coverage for the Edwards Lifesciences (EW) Sapien percutaneous aortic valve is the high perioperative complication rate of ischemic strokes, in excess of 9%, as well as femoral artery complications. The newer second generation Sapien XT, with a smaller diameter “French” profile, was hoped to reduce the complications and make the TAVR procedure safer. The newest data on the second-gen Sapien do not seem to support the claims from Marty Leon, financial backer of the valve, that the new valve is safer.
The PARTNER II study was presented at the ACC meeting in San Francisco. Continue reading
March 8, 2013 By Steven E. Greer, MD
We interviewed three of the oncologists and industry executives who spoke at the Damon Runyon Continue reading
Prashant Yadav, PhD, Director, Health Care Research Initiative, University of Michigan, discusses Continue reading
Gerald Brandacher, MD, Scientific Director of the Composite Tissue Allotransplantation (Reconstructive Transplant) Program at Johns Hopkins discusses the first double arm transplant.
Greer SE. Inside ObamaCare’s Grant-Making. Op-Ed in The Wall Street Journal. June 4, 2012
Greer SE. Pork is Clogging CMMI’s Arteries. Letter section in The Wall Street Journal. June 20, 2012
Interviewed by Steven E. Greer, MD
Barbara Giesser, MD, neurologist and Medical Director of the Multiple Sclerosis Center at UCLA, discusses the Continue reading
Manal F. Abdelmalek, MD, MPH, of the Duke Medical Center’s Division of Gastroenterology/Hepatology Continue reading
June 30, 2012, by Steven Greer, MD
The Supreme Court ruled that the PPACA “ObamaCare” law was constitutional in most aspects. Continue reading
June 24, 2012
CBS News interviewed the Governor of Massachusetts, Deval Patrick, about the cost increases Continue reading